A novel and highly differentiated immunomodulatory therapeutic based on Interleukin-21 (IL-21) activation. Our monoclonal antibody binds to and enhances IL-21, safely activating the immune system to treat cancer and chronic viral infections.
[更多]
 |
A novel and highly differentiated immunomodulatory therapeutic based on Interleukin-21 (IL-21) activation. Our monoclonal antibody binds to and enhances IL-21, safely activating the immune system to treat cancer and chronic viral infections.
[更多]
 |
ANU researchers have developed a sprayable solution that creates a two layer superhydrophobic nanocoating with excellent transmittance, durability, chemical resistance, and stability.
[更多]
| |< <- | [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] | -> >| |
